Paper42226306
Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.
Wu J and 9 others. Cancer Imaging, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma. Papers, record 42226306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226306
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Diffusion Magnetic Resonance Imaging | Major topic |
| Lymphoma | Major topic |
| Brain Neoplasms | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Male | |
| Diagnosis, Differential | |
| Adult | |
| Aged |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24814181 | Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. | Radiology | 2014 | https://conductscience.org/library/papers/24814181 | PubMed |
| 2 | 38946879 | Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/38946879 | PubMed |
| 3 | 34051685 | Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging. | Eur J Radiol | 2021 | https://conductscience.org/library/papers/34051685 | PubMed |
| 4 | 20677208 | Characterization of tissue structure at varying length scales using temporal diffusion spectroscopy. | NMR Biomed | 2010 | https://conductscience.org/library/papers/20677208 | PubMed |
| 5 | 35812103 | Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis. | Front Neurol | 2022 | https://conductscience.org/library/papers/35812103 | PubMed |
| 6 | 21330399 | Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. | AJNR Am J Neuroradiol | 2011 | https://conductscience.org/library/papers/21330399 | PubMed |
| 7 | 17805551 | Diffuse glioma growth: a guerilla war. | Acta Neuropathol | 2007 | https://conductscience.org/library/papers/17805551 | PubMed |
| 8 | 26225937 | Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter. | PLoS One | 2015 | https://conductscience.org/library/papers/26225937 | PubMed |
| 9 | 32662130 | Primary Central Nervous System Lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning. | J Magn Reson Imaging | 2021 | https://conductscience.org/library/papers/32662130 | PubMed |
| 10 | 27631626 | Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging. | PLoS One | 2016 | https://conductscience.org/library/papers/27631626 | PubMed |
| 11 | 35510125 | Multiparametric MR Imaging Features of Primary CNS Lymphomas. | Front Surg | 2022 | https://conductscience.org/library/papers/35510125 | PubMed |
| 12 | 36617263 | Histological and molecular classifications of pediatric glioma with time-dependent diffusion MRI-based microstructural mapping. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/36617263 | PubMed |
| 13 | 29104150 | Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging. | World Neurosurg | 2018 | https://conductscience.org/library/papers/29104150 | PubMed |
| 14 | 26384329 | Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors. | PLoS One | 2015 | https://conductscience.org/library/papers/26384329 | PubMed |
| 15 | 39371035 | CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/39371035 | PubMed |
| 16 | 27330520 | A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. | J Chiropr Med | 2016 | https://conductscience.org/library/papers/27330520 | PubMed |
| 17 | 33890149 | Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33890149 | PubMed |
| 18 | 30035121 | Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30035121 | PubMed |
| 19 | 37171492 | Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling. | Eur Radiol | 2023 | https://conductscience.org/library/papers/37171492 | PubMed |
| 20 | 29867979 | Immune Microenvironment in Glioblastoma Subtypes. | Front Immunol | 2018 | https://conductscience.org/library/papers/29867979 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226306
GET https://conductscience.org/api/papers/v1/42226306/references?page=2